Magnetic field detection using magnetohydrodynamic effect

• US 8,437,862 B2
• Filed: 03/29/2011
• Issued: 05/07/2013
• Est. Priority Date: 03/29/2011
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Yoon, Hyun J., Herberg, Ben W., Ellingson, Michael L.
• Primary Examiner(s): GETZOW, SCOTT M
• Application Number:
  US13/074,143
• Publication Number:
  US 20120253425A1
• Time in Patent Office: 770 Days
• Field of Search: 607 4- 28, 607/62, 607/63
• US Class Current: 607/63
• CPC Class Codes: A61N 1/3688 configured for switching the pacing mode, e.g. from AAI to DDD
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents
• CPC Class Codes: A61N 1/37217 characterised by the communication link, e.g. acoustic or tactile
• CPC Class Codes: A61N 1/3931 Protecting, e.g. back-up systems

Abstract

An IMD may transition to an MRI mode automatically in response to detecting one or more conditions indicative of the presence of a strong magnetic field. Large static magnetic fields, such as those produced by an MRI device, may interact with the blood of a patient as it flows through the magnetic field to produce a voltage, a phenomenon referred to as the magnetohydrodynamic (MHD) effect. The voltage produced by the MHD effect is proportional to the strength of the magnetic field. As such, the voltage produced by blood flow in the strong magnetic field of an MRI device may result in a change in a characteristic of an electrogram (EGM). The IMD may detect the change in the characteristic of the EGM caused by the MHD effect and transition to operation in the MRI mode in response to at least the change in the EGM.

Claims

1. A method comprising:

identifying a change in a characteristic of an electrogram (EGM) measured by an implantable medical device indicative of the presence of a static magnetic field, wherein the EGM corresponds to cardiac activity of a heart of a patient;

determining a magnitude of the change in the characteristic of the EGM;

detecting the presence of the static magnetic field based at least on the magnitude of the change in the characteristic of the EGM; and

adjusting operation of the implantable medical device in response to detecting the presence of the static magnetic field.

2. The method of claim 1, wherein identifying the change in the characteristic of the EGM indicative of the presence of a magnetic field comprises identifying a change in a T-wave of the EGM.

3. The method of claim 2, wherein identifying the change in the T-wave comprises one of identifying a change in an amplitude of the T-wave, a change in a duration of the T-wave, a change in a frequency component of the T-wave, and a change in a morphology of the T-wave.

4. The method of claim 1, wherein identifying a change in a characteristic of the EGM indicative of the presence of a magnetic field comprises identifying a change in a T-wave of the EGM in which at least one of the corresponding P-wave, R-wave and QRS complex is substantially unchanged.

5. The method of claim 1, wherein identifying the change in the characteristic of the EGM comprises identifying a change in an S-T segment of the EGM.

6. The method of claim 5, wherein identifying the change in the S-T segment of the EGM further comprises identifying the change in a duration of the S-T segment, a change in a frequency component of the S-T segment, and a change in a morphology of the S-T segment.

7. The method of claim 1, wherein identifying the change in the characteristic of the EGM comprises identifying a change in a ratio of an amplitude of one of an R-wave and a P-wave and an amplitude of a corresponding T-wave.

8. The method of claim 1, wherein adjusting operation of the implantable medical device comprises transitioning from a first operating mode to a second operating mode.

9. The method of claim 8, wherein the second operating mode comprises one of a magnet mode and a magnetic resonance imaging (MRI) mode.

10. An implantable medical system comprising:

at least one implantable medical lead that includes at least one electrode; and

an implantable medical device connected to the medical lead, the implantable medical device comprising a control module configured to identify a change in a characteristic of an electrogram (EGM) indicative of the presence of a static magnetic field, determine a magnitude of the change in the characteristic of the EGM, detect the presence of the static magnetic field based at least on the magnitude of the change in the characteristic of the EGM, and adjust operation of the implantable medical device in response to detecting the presence of the static magnetic field,

wherein the EGM corresponds to cardiac activity of a heart of a patient.

11. The system of claim 10, wherein the control module identifies a change in a T-wave of the EGM indicative of the presence of a magnetic field.

12. The system of claim 11, wherein the control unit identifies one of a change in an amplitude of the T-wave of the EGM, a change in a duration of the T-wave, a change in a frequency component of the T-wave, and a change in a morphology of the T-wave of the EGM indicative of the presence of a magnetic field.

13. The system of claim 10, wherein the control unit identifies a change in a T-wave of the EGM that corresponds with one of a P-wave, R-wave and QRS complex that is substantially unchanged.

14. The system of claim 10, wherein the control module identifies a change in an S-T segment of the EGM indicative of the presence of a magnetic field.

15. The system of claim 14, wherein the control module identifies a change in at least one of a duration of the S-T segment, a change in a frequency component of the S-T segment, and a change in a morphology of the S-T segment indicative of the presence of a magnetic field.

16. The system of claim 10, wherein the control module identifies a change in the EGM indicative of the presence of a magnetic field upon identifying a change in a ratio of an amplitude of one of an R-wave and a P-wave and an amplitude of a corresponding T-wave.

17. The system of claim 10, wherein adjusting operation of the implantable medical device comprises transitioning from a first operating mode to a second operating mode.

18. The system of claim 10, wherein the second operating mode comprises one of a magnet mode and a magnetic resonance imaging (MRI) mode.

19. A computer-readable medium comprising instructions that, when executed, cause an implantable medical device to:

identify a change in a characteristic of an electrogram (EGM) indicative of the presence of a static magnetic field, wherein the EGM corresponds to cardiac activity of a heart of a patient;

determine a magnitude of the change in the characteristic of the EGM;

detect the presence of the static magnetic field based at least on the magnitude of the change in the characteristic of the EGM; and

adjust operation of the implantable medical device in response to detecting the presence of the static magnetic field.